Different variables (age, sex, time in therapy with BIC-STR, time in ART pre-switch, previous opportunistic infections, HCV or HBV coinfections, comorbidities more than one, nadir CD4 count, zenith HIV-RNA) were included in the univariate analysis. This evidence concerns the gene CD4 and Opportunistic infection.